Therapeutic Solutions International develops, produces and markets technologies and therapeutic modalities to treat and prevent common neurologic, sleep and temporomandibular disorders. The company has signed a letter of intent under which it will receive from S4S (NASDAQ:UK) Limited the exclusive U.S. distribution rights to market patented and FDA-cleared titratable sleep appliance hardware.
"This letter of intent with TSI is one more forward step in our ever growing relationship," Matt Everatt, technical director of S4S (UK) stated in the press release. "We are very excited about TSI exclusively distributing our sleep appliance hardware in the U.S. and look forward to completing a definitive agreement."
Oral appliances help maintain an open airway during sleep, promoting adequate air intake. The appliances can be used alone or in combination with other treatments for sleep-related breathing disorders. Acquiring the rights to distribute the sleep appliance hardware provides a doorway for TSOI to enter into the dental sleep market and the change to enhance its nationwide presence.
"Our alliance with S4S has provided us an opportunity to introduce a new product into the U.S. marketplace," Tim Dixon, CEO of TSOI stated. "We have been working on this collaboration with S4S and look forward to a long and rewarding relationship. According to the American Academy of Dental Sleep Medicine, 'More than 18 million Americans have sleep apnea, and many are not receiving treatment': We intend to play a role in the treated and untreated with our sleep appliance hardware."
For more information visit therapeuticsolutionsint.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net